Literature DB >> 7543690

Molecular implications of the antiandrogen withdrawal syndrome.

J W Moul1, S Srivastava, D G McLeod.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7543690

Source DB:  PubMed          Journal:  Semin Urol        ISSN： 0730-9147


× No keyword cloud information.
  6 in total

1.  Androgen receptor decoy molecules block the growth of prostate cancer.

Authors:  Steven N Quayle; Nasrin R Mawji; Jun Wang; Marianne D Sadar
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-16       Impact factor: 11.205

Review 2.  Small molecule inhibitors targeting the "achilles' heel" of androgen receptor activity.

Authors:  Marianne D Sadar
Journal:  Cancer Res       Date:  2011-02-01       Impact factor: 12.701

3.  Novel Androgen Deprivation Therapy (ADT) in the Treatment of Advanced Prostate Cancer.

Authors:  Jeanny B Aragon-Ching; William L Dahut
Journal:  Drug Discov Today Ther Strateg       Date:  2010-07-01

4.  Molecular processes leading to aberrant androgen receptor signaling and castration resistance in prostate cancer.

Authors:  Rong Hu; Samuel R Denmeade; Jun Luo
Journal:  Expert Rev Endocrinol Metab       Date:  2010-09

Review 5.  Androgen-independent prostate cancer: potential role of androgen and ErbB receptor signal transduction crosstalk.

Authors:  Soha Salama El Sheikh; Jan Domin; Paul Abel; Gordon Stamp; El-Nasir Lalani
Journal:  Neoplasia       Date:  2003 Mar-Apr       Impact factor: 5.715

Review 6.  Prostate cancer stem cells.

Authors:  Hanna Romańska-Knight; Paul Abel
Journal:  Cent European J Urol       Date:  2011-12-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.